Search Results 1571-1580 of 16070 for ozempic

  1. Women's Wellness: Libido Pill for Women Approved - Mayo Clinic News Network

    The U.S. Food and Drug Administration has approved Addyi (flibanserin) – making it the first and only drug designed to help increase women's sexual desire.

  2. Olipudase alfa-rpcp (intravenous route) - Mayo Clinic

    Olipudase alfa-rpcp injection is used to treat non-central nervous system symptoms of acid sphingomyelinase deficiency (ASMD). ASMD is a genetic disease that ...

  3. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  4. Drug Allergy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate a serum IgE hemp antibody immunoassay for use in the evaluation of allergies to cannabis and other hemp products.

  5. Publications - Shounak Majumder, M.D. - Mayo Clinic

    Wang L, Vatsavayi P, Majumder S, Gleeson FC, Rajan E, Abu Dayyeh BK, Storm AC, Umar S, Velaga ST, Harmsen WS, Vege SS, Chandrasekhara V. Trends and impact ...

  6. Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures. - Mayo Clinic

    About this study. Plastic biliary stents which are a new larger size will remain free of obstructions for a longer period of time than currently used 10 ...

  7. Butyrate Adjuvant Therapy for Type 1 Diabetes - Mayo Clinic

    About this study. This study will test the efficacy of BKR-017 (colon-targeted 500 mg butyrate tablets) on insulin sensitivity, glucose control and ...

  8. Publications - Matej Markota, M.D. - Mayo Clinic

    Allen O 4th, Coombes BJ, Pazdernik V, Gisabella B, Hartley J, Biernacka JM, Frye MA, Markota M, Pantazopoulos H. Differential serum levels of CACNA1C, ...

  9. Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis - Mayo Clinic

    The purpose of this study is to determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker ...